Citation: Kk. Midha et al., Realities and implementation - report of the International Workshop on IBE, Montreal, Canada, August 1999, EUR J DRUG, 25(1), 2000, pp. 63-63
Authors:
Fang, J
McKay, G
Hubbard, JW
Hawes, EM
Midha, KK
Citation: J. Fang et al., Dose staggering as a strategy to reduce drug-drug interactions due to reversible enzyme inhibition between orally administered drugs with high first pass effect: A computer simulation study, BIOPHARM DR, 21(7), 2000, pp. 249-259
Authors:
Dvorchik, BH
Gaynes, BI
Hubbard, JW
Kirk, JK
Kobayashi, K
Sokol, GH
Citation: Bh. Dvorchik et al., American College of Clinical Pharmacology response to the Institute of Medicine report "To err is human: Building a safer health system", J CLIN PHAR, 40(10), 2000, pp. 1075-1078
Authors:
Midha, KK
Hubbard, JW
McKay, G
Rawson, MJ
Hsia, D
Citation: Kk. Midha et al., The role of metabolites in a bioequivalence study II: amoxapine, 7-hydroxyamoxapine, and 8-hydroxyamoxapine, INT J CL PH, 37(9), 1999, pp. 428-438
Authors:
Hubbard, JW
Hadad, S
Luo, JP
McKay, G
Midha, KK
Citation: Jw. Hubbard et al., Pharmacokinetics of fluphenazine, a highly lipophilic drug, estimated froma pulse dose of a stable isotopomer in dogs at steady state, J PHARM SCI, 88(9), 1999, pp. 918-921